NYSE ARCA | ETF
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 23.46% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 20.87% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 5.08% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 5.03% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.54% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.43% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.41% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 4.26% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.17% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.88% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 3.05% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.95% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.67% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 1.52% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 1.39% |
| INDV | Indivior PLC Ordinary Shares | Healthcare | Drug Manufacturers - Specialty & Generic | 1.27% |
| TERN | Terns Pharmaceuticals Inc | Healthcare | Biotechnology | 1.26% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 1.25% |
| LQDA | Liquidia Technologies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.11% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 1.01% |